We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: 12 investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Cloud-based SaaS software with the purpose of efficiently generating corporate management reports to reduce operational costs and improve data quality. Synapse's service can be implemented into pre-existing financial reporting systems to produce automated reports, even in large companies. Customers include Lloyds Bank, who have signed a 2-year term and the Bank of England have contacted Synapse to potentially integrate the system.
days to go: Expired investment: £894,056
nHouse supplies modular method eco-friendly homes and by building homes in controlled factory enviroments, each module is defect-free before being transported to the site for assembly, resulting in cost saving and increase customizability. Their homes boast energy efficiency with A rating at EPC, resulting in minimized energy costs for occupants and redice carbon emissions. 
days to go: Expired investment: £183,839
Using artificial intelligence to accurately match a person's CV with a business's job requirements. Recruitment Smart have developed SniperAI, a tool created by specialists and a researcher from Carnegie Mellon University to quickly search and scan the ideal candidate for a specific job role. This technology can be integrated into a company's job listings to automatically screen submitted CVs and returns a suitability score. In addition, as HR departments are under constant scrutiny to provide information on equality in the workplace, SniperAI can offer a list of appropriate candidates without bias. Recruitment Smart will generate revenue from initial set-up costs and licensing the product to businesses.
days to go: Expired investment: £272,650
White Peak Distillery (WPD) is a whisky distillery that aims to change the way whisky is made and create authentic flavours. It has so far invested £1.4 million in tried and tested plant equipment producing 400,000 bottles of maturing whisky. The company aims to become a contender in the $60 billion global premium whisky market. WPD has received 'Gold Awards' from The Wizards of Whisky World Whisky Awards. It has come out with programs to monetise its maturing whisky including its Cask Sales program, Temperance Club membership and its Prologue 2.1 release 2-year aged single malt spirit, that has been received with positive feedback. WPD has also been awarded visitor business in The Peak District, which receives 13 million+ visitors per annum, boosting its Direct-to-Consumer (D2C) model. It will use the investment to grow its business across different verticals.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,301,320
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph